The present invention provides pyrimidinones that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
本发明提供了
嘧啶酮,其调节
磷脂酰肌醇3-激酶(
PI3Ks)的活性,并可用于治疗与
PI3Ks活性相关的疾病,包括但不限于炎症性疾病、免疫性疾病、癌症和其他疾病。